Hologic Inc at Raymond James Institutional Investors Conference Transcript

Mar 08, 2022 / 02:50PM GMT
Andrew Harris Cooper - Raymond James & Associates, Inc., Research Division - Senior Research Associate

Good morning. Welcome to day 2 of the Raymond James Institutional Investor Conference. I'm Andrew Cooper. I cover diagnostics here at Raymond James. We're excited to have Hologic joining us this morning, so a company that you've probably heard the name of for COVID. If you hadn't prior, but there's a heck of a lot more to the story. We're going to get into that.

I'm joined by CFO, Karleen Oberton, for a fireside chat; as well as Ryan Simon, who heads up the IR efforts. So maybe just to start, if you don't mind, for some folks maybe newer to the story, can you give us a little bit of a quick intro to who Hologic is, what you do, some of the markets you play in, and just sort of an overview in general?

Karleen M. Oberton - Hologic, Inc. - CFO

Sure. Absolutely, and thank you, Andrew, for having us today, where it's a pleasure to be here. It's certainly a pleasure to be here in person, first in-person conference in 2 years, so this is really special.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot